Trial
NCT05977322
A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Pancreatic Ductal Adenocarcinoma
Intervention
68Ga-FF58
Why stopped
The decision was not based on any safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-24